4.20
price down icon0.94%   -0.04
 
loading
Precedente Chiudi:
$4.24
Aprire:
$4.33
Volume 24 ore:
5,175
Relative Volume:
0.39
Capitalizzazione di mercato:
$209.61M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-5.7213
EPS:
-0.7341
Flusso di cassa netto:
-
1 W Prestazione:
-6.67%
1M Prestazione:
-29.94%
6M Prestazione:
-5.41%
1 anno Prestazione:
+30.03%
Intervallo 1D:
Value
$4.17
$4.33
Intervallo di 1 settimana:
Value
$4.17
$4.43
Portata 52W:
Value
$3.08
$6.4229

Genfit Adr Stock (GNFT) Company Profile

Name
Nome
Genfit Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
167
Name
Cinguettio
@genfit_pharma
Name
Prossima data di guadagno
2024-09-19
Name
Ultimi documenti SEC
Name
GNFT's Discussions on Twitter

Confronta GNFT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
GNFT 4.20 209.61M 0 0 0 -0.7341
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Genfit Adr Stock (GNFT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-12-20 Aggiornamento H.C. Wainwright Neutral → Buy
2020-07-23 Aggiornamento Stifel Hold → Buy
2020-06-25 Iniziato BofA/Merrill Underperform
2020-05-13 Downgrade Kepler Buy → Reduce
2020-05-12 Downgrade Barclays Overweight → Equal Weight
2020-05-12 Downgrade H.C. Wainwright Buy → Neutral
2019-10-29 Reiterato B. Riley FBR Buy
2019-06-25 Iniziato Stifel Hold
2019-04-24 Iniziato SVB Leerink Outperform
2019-04-22 Iniziato Barclays Overweight
Mostra tutto

Genfit Adr Borsa (GNFT) Ultime notizie

pulisher
Nov 15, 2024

Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with PBC with improvements in fatigue and pruritus - GlobeNewswire Inc.

Nov 15, 2024
pulisher
Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Slightly Higher - MSN

Oct 09, 2024
pulisher
Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading - MSN

Oct 09, 2024
pulisher
Sep 29, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - MSN

Sep 29, 2024
pulisher
Sep 26, 2024

European Equities Traded in the US as American Depositary Receipts Move Higher in Tuesday Trading - MSN

Sep 26, 2024
pulisher
Sep 21, 2024

European Equities Traded in the US as American Depositary Receipts Decrease Friday - MSN

Sep 21, 2024
pulisher
Sep 19, 2024

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - MSN

Sep 19, 2024
pulisher
Sep 13, 2024

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - MSN

Sep 13, 2024
pulisher
Sep 08, 2024

European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading - MSN

Sep 08, 2024
pulisher
Sep 06, 2024

European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading - MSN

Sep 06, 2024
pulisher
Sep 06, 2024

European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading - MSN

Sep 06, 2024
pulisher
Aug 30, 2024

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN

Aug 30, 2024
pulisher
Aug 21, 2024

European Equities Traded in the US as American Depositary Receipts Trend Slightly Higher in Wednesday Trading - MSN

Aug 21, 2024
pulisher
Jul 22, 2024

European Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher in Monday Trading - MSN

Jul 22, 2024
pulisher
Jul 09, 2024

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - GlobeNewswire Inc.

Jul 09, 2024
pulisher
Jul 02, 2024

European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading - MSN

Jul 02, 2024
pulisher
Jun 28, 2024

European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN

Jun 28, 2024
pulisher
Jun 18, 2024

Genfit: New EASL-EASD-EASO guidelines include NIS2+TipRanks.com - TipRanks

Jun 18, 2024
pulisher
Jun 18, 2024

European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading - MSN

Jun 18, 2024
pulisher
Jun 14, 2024

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading - MSN

Jun 14, 2024
pulisher
Jun 10, 2024

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary ... - GlobeNewswire

Jun 10, 2024
pulisher
Jun 10, 2024

GENFIT: Historic Milestone Achieved with U.S. FDA - GlobeNewswire

Jun 10, 2024
pulisher
Jun 05, 2024

Home / Today's Market - InvestorPlace

Jun 05, 2024
pulisher
Jun 03, 2024

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - MSN

Jun 03, 2024
pulisher
Jun 01, 2024

Is Genfit (GNFT) Stock a Solid Choice Right Now - Yahoo Movies UK

Jun 01, 2024
pulisher
May 31, 2024

European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Wednesday Trading - MSN

May 31, 2024
pulisher
May 30, 2024

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading - MSN

May 30, 2024
pulisher
May 22, 2024

European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading - MSN

May 22, 2024
pulisher
Nov 20, 2023

European Equities Traded in the US as American Depositary Receipts Start Week Higher - MSN

Nov 20, 2023
pulisher
Nov 13, 2023

Results from Ipsen’s ELATIVE® pivotal Phase III trial of elafibranor in PBC presented as late breaking data at AASLD congress and published in New England Journal of Medicine - Ipsen

Nov 13, 2023
pulisher
Jun 30, 2023

Ipsen and GENFIT Announce Positive Results from Phase III ELATIVE trial of elafibranor in patients with primary biliary cholangitis, a rare cholestatic liver disease - Ipsen

Jun 30, 2023
pulisher
Apr 14, 2022

All You Need to Know About Flex (FLEX) Rating Upgrade to Strong Buy - Zacks Investment Research

Apr 14, 2022
pulisher
Jan 11, 2022

Can GENFIT S.A. Unsponsored ADR (GNFT) Climb 79% to Reach the Level Wall Street Analysts Expect? - Yahoo New Zealand News

Jan 11, 2022
pulisher
Dec 18, 2021

Ipsen und GENFIT schließen im Rahmen einer langfristigen globalen Partnerschaft eine exklusive Lizenzvereinbarung für Elafibranor ab, ein Phase-III-Asset, das für die Behandlung von primärer biliärer Cholangitis geprüft wird - Business Wire

Dec 18, 2021
pulisher
Dec 17, 2021

GENFIT: Ipsen and GENFIT enter into exclusive licensing - GlobeNewswire

Dec 17, 2021
pulisher
Aug 28, 2020

Intercept (ICPT) Posts New Positive Results on NASH Drug - Yahoo Movies UK

Aug 28, 2020
pulisher
May 26, 2020

Intercept Down on Postponement of AdCom Meet for NASH Drug - Yahoo Movies UK

May 26, 2020
pulisher
Jun 27, 2019

The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO - Yahoo Finance

Jun 27, 2019
pulisher
Jun 12, 2019

The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana - Yahoo Finance

Jun 12, 2019
pulisher
Apr 22, 2019

Genfit (GNFT) Stock Price, News & AnalysisNASDAQ - MarketBeat

Apr 22, 2019
pulisher
Apr 09, 2019

The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing - Yahoo Finance

Apr 09, 2019

Genfit Adr Azioni (GNFT) Dati Finanziari

Non sono disponibili dati finanziari per Genfit Adr (GNFT). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
Capitalizzazione:     |  Volume (24 ore):